Advances in the characterization of a proteol iposome derived from Mycobacterium bovis BCG as vaccine candidate against tuberculosis

Advances in the characterization of a proteol iposome derived from Mycobacterium bovis BCG as vaccine candidate against tuberculosis

Despite efforts to eradicate tuberculosis (TB) worldwide, this remains a serious health problem. The Bacillus Calmette-Guerin (BCG), the only available vaccine against TB, has variable efficacy and though protects against severe forms of the disease in childhood, has a questionable role in the pr...

Full description

Bibliographic Details
Main Authors: Nadine Alvarez-Cabrera, Sonsire Fernández-Castillo, Daymí Serpa-Almaguer, Daily Serrano-Hernández, Caridad Zayas-Vignier, Rubén Adonis Cabrera-Arias, Reinaldo Acevedo-Grogues, Vladimir Peña-Sánchez, Norazmi Mohd-Nor, María Elena Sarmiento-García-San Miguel, Armando Acosta-Domínguez, José Luis Pérez- Quiñoy
Format: Article
Language:English
Published: Finlay Ediciones 2014-12-01
Series:VacciMonitor
Subjects:
tuberculosis
vaccine
proteoliposome
Mycobacterium bovis BCG
Online Access:http://scielo.sld.cu/scielo.php?script=sci_pdf&pid=S1025-028X2014000300005&lng=es&nrm=iso&tlng=es

Internet

http://scielo.sld.cu/scielo.php?script=sci_pdf&pid=S1025-028X2014000300005&lng=es&nrm=iso&tlng=es

Similar Items